Protective role of c‐Jun N‐terminal kinase‐2 (JNK2) in ibuprofen‐induced acute liver injury
- 11 December 2018
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 247 (1) , 110-122
Abstract
Ibuprofen is a worldwide used non‐steroidal anti‐inflammatory drug (NSAID) which may cause acute liver injury (ALI) requiring liver transplantation. We aimed to unveil the molecular pathways involved in triggering ibuprofen‐induced ALI, which, at present, remain elusive. First, we investigated activation of essential pathways in human liver sections of ibuprofen‐induced ALI. Next, we assessed the cytotoxicity of ibuprofen in vitro and developed a novel murine model of ibuprofen intoxication. To assess the role of JNK, we used animals carrying constitutive deletion of c‐Jun N‐terminal kinase 1 (Jnk1‐/‐) or Jnk2 (Jnk2‐/‐) expression and included investigations using animals with hepatocyte‐specific Jnk deletion either genetically (Jnk1Δhepa) or by siRNA (siJnk2Δhepa). We found in human and murine samples of ibuprofen‐induced acute liver failure (ALF) that JNK phosphorylation was increased in the cytoplasm of hepatocytes and other non‐liver parenchymal cells (LPCs) compared with healthy tissue. In mice, ibuprofen intoxication resulted in a significantly stronger degree of liver injury compared with vehicle‐treated controls as evidenced by serum transaminases, and hepatic histopathology. Next, we investigated molecular pathways. PKCα, AKT, JNK and RIPK1 were significantly increased 8 h after ibuprofen intoxication. Constitutive Jnk1‐/‐ and Jnk2‐/‐ deficient mice exhibited increased liver dysfunction compared to wildtype (WT) animals. Furthermore, siJnk2Δhepa animals showed a dramatic increase in biochemical markers of liver function, which correlated with significantly higher serum liver enzymes and worsened liver histology, and MAPK activation compared to Jnk1Δhepa or WT animals. In our study, cytoplasmic JNK activation in hepatocytes and other non‐LPCs is a hallmark of human and murine ibuprofen‐induced ALI. Functional in vivo analysis demonstrated a protective role of hepatocyte‐specific Jnk2 during ibuprofen ALI.Keywords
Funding Information
- Consejería de Educación, Juventud y Deporte, Comunidad de Madrid (EXOHEP‐CM S2017/BMD‐3727)
- Deutsche Forschungsgemeinschaft (DFG‐EI/ZUK2/I3TM/SF_15_5_17, DFG/Tr 285 10‐1)
- Secretaría de Estado de Investigación, Desarrollo e Innovación (RETOS SAF2016‐78711)
This publication has 44 references indexed in Scilit:
- CYP2E1 Sensitizes the Liver to LPS- and TNFα-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated KinasesInternational Journal of Hepatology, 2011
- Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase InhibitionGastroenterology, 2010
- Phenotypic characterization of idiosyncratic drug‐induced liver injuryHepatology, 2009
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injuryBiochemical and Biophysical Research Communications, 2008
- Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug‐induced idiosyncratic liver injury (DILI)British Journal of Pharmacology, 2007
- Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failureGut, 2006
- Tumor Necrosis Factor-induced Toxic Liver Injury Results from JNK2-dependent Activation of Caspase-8 and the Mitochondrial Death PathwayJournal of Biological Chemistry, 2006
- Acute vanishing bile duct syndrome after ibuprofen therapy in a childThe Journal of Pediatrics, 2004
- Lymphopenia and hepatic toxicity with ibuprofenThe Journal of Pediatrics, 1977